King's College London

Research portal

Role of the lysophosphatidylinositol/GPR55 axis in cancer

Research output: Contribution to journalReview articlepeer-review

Marco Falasca, Riccardo Ferro

Original languageEnglish
Pages (from-to)88-93
Number of pages6
JournalAdvances in biological regulation
Early online date28 Oct 2015
Accepted/In press2 Oct 2015
E-pub ahead of print28 Oct 2015
PublishedJan 2016

King's Authors


Lysophosphatidylinositol (LPI) is a well-known bioactive lipid that is able to activate signalling cascades relevant to cell proliferation, migration, survival and tumourigenesis. It is well-established that the G protein-coupled receptor 55 (GPR55) is the specific receptor for LPI. Several investigations have demonstrated that the signalling pathways activated by LPI through its receptor GPR55 play a pivotal role in different cancer type. This review focuses on the role of the LPI/GPR55 axis, in particular with regards to its pharmacological potential therapeutic exploitation.

View graph of relations

© 2020 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454